HD Lifesciences Surpasses 2500 Implant Milestone For Hive™ Interbody Fusion Device

Aug 11, 2020

BOSTON, MA – HD Lifesciences, LLC, a medical device company, has announced it has surpassed the milestone of 2500 implanted HIVE interbody devices since the formation of the company in late 2017.

Hive Soft Titanium® combines the benefit of high definition 3D printed titanium with a proprietary NanoHive® surface treatment. The Soft Titanium® structural lattice design provides the ability to control implant stiffness while offering unrivaled durability. Hive technology with NanoHive® surfacing provides the ideal elastic modulus, diagnostic imaging, and osteogenic properties.

“HD started with the goal of creating the ideal structural lattice for orthopedic and spine applications,” says David Rattigan, Vice President of Sales. “We are very proud of reaching this milestone. Surgeons understand the progression of spinal implant materials, and we believe Hive implants are at the forefront of spinal fusion technology.”

HD Lifesciences, LLC interbody fusion devices are proudly made in the USA.

NanoHive Medical, LLC is a pioneer and leading innovator in 3D printed spinal interbody fusion implants and instrumentation. The company’s proprietary, biomimetic Soft Titanium® technology clearly distinguishes their products in the $1.9B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provide surgeons and their patients ideal biomechanical elastic modulus properties, clear and precise diagnostic imaging capability, osteoblast cell attraction and integration – all features that lead to consistently strong fusion constructs and efficacious clinical experiences.

NanoHive Medical is located in Woburn, Massachusetts U.S.A.

Contact: Patrick O’Donnell, CEO & President at Patrick.odonnell@nanohive.com

Website: www.nanohive.com